These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 28550479)

  • 1. Biomolecular diagnosis of myotonic dystrophy type 2: a challenging approach.
    Meola G; Biasini F; Valaperta R; Costa E; Cardani R
    J Neurol; 2017 Aug; 264(8):1705-1714. PubMed ID: 28550479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical aspects, molecular pathomechanisms and management of myotonic dystrophies.
    Meola G
    Acta Myol; 2013 Dec; 32(3):154-65. PubMed ID: 24803843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myotonic dystrophy type 2 and modifier genes: an update on clinical and pathomolecular aspects.
    Meola G; Cardani R
    Neurol Sci; 2017 Apr; 38(4):535-546. PubMed ID: 28078562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic odyssey of patients with myotonic dystrophy.
    Hilbert JE; Ashizawa T; Day JW; Luebbe EA; Martens WB; McDermott MP; Tawil R; Thornton CA; Moxley RT
    J Neurol; 2013 Oct; 260(10):2497-504. PubMed ID: 23807151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and Validation of a New Molecular Diagnostic Assay for Detection of Myotonic Dystrophy Type 2.
    Valaperta R; Lombardi F; Cardani R; Fossati B; Brigonzi E; Merli I; Sansone V; Merletti G; Spina E; Meola G; Costa E
    Genet Test Mol Biomarkers; 2015 Dec; 19(12):703-9. PubMed ID: 26505324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Muscle pathology in myotonic dystrophy: light and electron microscopic investigation in eighteen patients.
    Nadaj-Pakleza A; Lusakowska A; Sułek-Piątkowska A; Krysa W; Rajkiewicz M; Kwieciński H; Kamińska A
    Folia Morphol (Warsz); 2011 May; 70(2):121-9. PubMed ID: 21630234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myotonic dystrophies: An update on clinical aspects, genetic, pathology, and molecular pathomechanisms.
    Meola G; Cardani R
    Biochim Biophys Acta; 2015 Apr; 1852(4):594-606. PubMed ID: 24882752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myotonic dystrophy type 2: the 2020 update.
    Meola G
    Acta Myol; 2020 Dec; 39(4):222-234. PubMed ID: 33458578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Myotonic dystrophies: clinical presentation, pathogenesis, diagnostics and therapy].
    Finsterer J; Rudnik-Schöneborn S
    Fortschr Neurol Psychiatr; 2015 Jan; 83(1):9-17. PubMed ID: 25602187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The myotonic dystrophies: diagnosis and management.
    Turner C; Hilton-Jones D
    J Neurol Neurosurg Psychiatry; 2010 Apr; 81(4):358-67. PubMed ID: 20176601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severity, type, and distribution of myotonic discharges are different in type 1 and type 2 myotonic dystrophy.
    Logigian EL; Ciafaloni E; Quinn LC; Dilek N; Pandya S; Moxley RT; Thornton CA
    Muscle Nerve; 2007 Apr; 35(4):479-85. PubMed ID: 17230537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myotonic dystrophy: from bench to bedside.
    Johnson NE; Heatwole CR
    Semin Neurol; 2012 Jul; 32(3):246-54. PubMed ID: 23117949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Greek National Cross-Sectional Study on Myotonic Dystrophies.
    Papadimas GK; Papadopoulos C; Kekou K; Kartanou C; Kladi A; Nitsa E; Sofocleous C; Tsanou E; Sarmas I; Kaninia S; Chroni E; Tsivgoulis G; Kimiskidis V; Arnaoutoglou M; Stefanis L; Panas M; Koutsis G; Karadima G; Traeger-Synodinos J
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and molecular aspects of the myotonic dystrophies: a review.
    Machuca-Tzili L; Brook D; Hilton-Jones D
    Muscle Nerve; 2005 Jul; 32(1):1-18. PubMed ID: 15770660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myotonic dystrophy: emerging mechanisms for DM1 and DM2.
    Cho DH; Tapscott SJ
    Biochim Biophys Acta; 2007 Feb; 1772(2):195-204. PubMed ID: 16876389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The current clinical perception of myotonic dystrophy type 2.
    Kleefeld F; Schoser B
    Curr Opin Neurol; 2023 Oct; 36(5):474-478. PubMed ID: 37639480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myotonic dystrophies type 1 and 2: anesthetic care.
    Veyckemans F; Scholtes JL
    Paediatr Anaesth; 2013 Sep; 23(9):794-803. PubMed ID: 23384336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and genetic heterogeneity in myotonic dystrophies.
    Meola G
    Muscle Nerve; 2000 Dec; 23(12):1789-99. PubMed ID: 11102902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomolecular identification of (CCTG)n mutation in myotonic dystrophy type 2 (DM2) by FISH on muscle biopsy.
    Cardani R; Mancinelli E; Sansone V; Rotondo G; Meola G
    Eur J Histochem; 2004; 48(4):437-42. PubMed ID: 15718211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value of short exercise and short exercise with cooling tests in the diagnosis of myotonic dystrophies (DM1 and DM2).
    Gawel M; Szmidt-Salkowska E; Lusakowska A; Nojszewska M; Sulek A; Krysa W; Rajkiewicz M; Seroka A; Kaminska AM
    Muscle Nerve; 2014 Feb; 49(2):277-83. PubMed ID: 23716346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.